Urinary bladder MR imaging. Part II. Neoplasm.
The potential of magnetic resonance (MR) imaging for the evaluation and staging of bladder tumors was analyzed in 15 patients (11 cases of transitional cell carcinoma, two adenocarcinomas, one leiomyosarcoma, and one leiomyoma). Neoplasms were characterized by size, site, and growth pattern, and the accuracy of the staging was compared with the results of computed tomography and pathologic study. Malignancies were accurately detected and staged by MR imaging in 12 of 14 patients (85%). Tumor site and degree of bladder distention did not adversely affect detection; tumors greater than 1.5 cm were detected easily. In situ carcinoma (stage Tis) was not detected on MR images. Imaging in both sagittal and transverse planes was needed for optimal bladder evaluation. Bladder carcinoma was best displayed with a short echo delay time (TE) of 28 msec and repetition (TR) times of 1.0-2.0 sec: TR = 1.0 gave 34% contrast and TR = 2.0 gave 36% contrast between tumor and surrounding urine. Bladder-wall invasion by tumor was best evaluated with long TR (2.0 sec) and long TE (56 msec) (82% contrast). For assessing tumor extension into perivesical fat, short TR (0.5 sec) and TE (28 msec) were optimal (58% contrast). MR imaging offers an increased sensitivity for tumor detection and promises to greatly improve the staging of bladder neoplasms.
D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000473:pathology